Evidence map›Paper›PMID 36978380›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Characterization of Third Generation Cephalosporin- and Carbapenem-Resistant

Sara Drk, Ana Puljko, Mia Dželalija, Nikolina Udiković-Kolić

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. CharacterizingAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Pathogens (Basel, Switzerland) · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Carbapenem-resistant bacteria in the environment.Arhiv za higijenu rada i toksikologiju · 2025
    Review
  12. mBio · 2025
    Article
  13. Article
  14. Article
  15. ExploringVeterinary sciences · 2025
    Article
  16. Rapid detection of carbapenemase production inJournal of clinical microbiology · 2025
    Article
  17. Article
  18. Phylogenomics of novel clones ofMicrobiology spectrum · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sara DrkDivision for Marine and Environmental Research, Ruđer Bošković Institute, Bijenička 54, 10 002 Zagreb, Croatia.
Ana PuljkoDivision for Marine and Environmental Research, Ruđer Bošković Institute, Bijenička 54, 10 002 Zagreb, Croatia.
Mia DželalijaDepartment of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21 000 Split, Croatia.ORCID 0000-0002-7284-9519
Nikolina Udiković-KolićDivision for Marine and Environmental Research, Ruđer Bošković Institute, Bijenička 54, 10 002 Zagreb, Croatia.
Ruđer Bošković Institute · HRUniversity of Split · HR

Funding

Croatian Science Foundation IP-2019-04-5539
6 · The paper itself

Abstract

Antibiotic resistance (AR) remains one of the greatest threats to global health, and

Indexed as

AeromonasAmpCcarbapenemaseESBLhospital wastewatermunicipal wastewaterplasmid transfer

Identifiers

PMID36978380
PMCPMC10044312
OpenAlexW4323318883

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read130
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.